Santero Therapeutics logo — company profile

Santero Therapeutics

Founded 2021 2-10 employees Series A Total: $8.00M Biotechnology, Health Care +1

General Information

Company Name Santero Therapeutics
Founded Year 2021
Employees 2-10
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Santero Therapeutics. To contact Santero Therapeutics, visit santero.be.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Santero Therapeutics compare?

A PDF of Santero Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Santero Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Santero Therapeutics

Santero Therapeutics, established in 2021, aims to revolutionize medication by introducing innovative approaches to combat diseases with high resistance levels. The company specializes in developing antipathogen agents with unique mechanisms to tackle the growing challenge of antibiotic-resistant microbes. With its focus on biotechnology, health care, and health and wellness industries, Santero Therapeutics secured a significant €8.00M Series A investment on 08 June 2023. The investment was led by Newton BioCapital, Sambrinvest, SFPIM, Pierre Drion, and S.R.I.W.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €8.00M 5
Newton BioCapital, Sambrinvest +3
08 Jun 2023

Santero Therapeutics Alternatives & Competitors

View All Alternatives
Santero Therapeutics vs

Phico Therapeutics is a biotechnology company advancing the war on antibiotic resistance with engine...

Venture round
10 employees
Biopharma, Biotechnology
Santero Therapeutics vs

Combating antibiotic resistance through innovative genomic testing to ensure treatable infections re...

Pre-Seed
Biotechnology, Health Care
Santero Therapeutics vs

Sequella is a private, clinical-stage pharmaceutical company that addresses the challenge of antibio...

Venture round
6 employees
Biotechnology, Health Care

FAQ About Santero Therapeutics

Santero Therapeutics aims to introduce new medications featuring unique mechanisms to tackle diseases with high resistance levels. The company is focused on creating antipathogen agents with innovative actions to address the increasing issue of antibiotic-resistant microbes.
Santero Therapeutics was founded in 2021.
Santero Therapeutics operates in Biotechnology, Health Care and Health and Wellness.
Santero Therapeutics has approximately 2-10 employees.
Santero Therapeutics has completed 1 funding round, raising a total of $8.00M. The latest funding stage is Series A.
Top alternatives and competitors to Santero Therapeutics include Phico Therapeutics Ltd., Shield Bio, Sequella, Inc., Microbion Corporation, Cirius Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Santero Therapeutics and Phico Therapeutics Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Santero Therapeutics, https://bouncewatch.com/company/santero-therapeutics, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes